Form 4 Filing for Aura Biosciences, Inc.
2026-06-16SEC Filing 4 (0001193125-26-272703)
This Form 4 filing details a transaction by Gibney Anthony S, Chief Financial and Business Officer of Aura Biosciences, Inc. On June 16, 2026, Mr. S sold 12,824 shares of Common Stock at a price of $6.42 per share. This sale was conducted to cover tax withholding obligations associated with the vesting of restricted stock units. The transaction was automatic and not at the discretion of the reporting person. Following this transaction, Mr. S owns 265,354 shares of Common Stock. The filing was made under Form 4 and is related to an officer transaction.